FSB Premier Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Buy
542
+216
+66% +$221K 0.18% 127
2026
Q1
$300K Buy
+326
New +$331K 0.09% 194
2022
Q1
Sell
-112
Closed -$30K 353
2021
Q4
$30K Buy
+112
New +$28.4K 0.01% 301

Other funds holding LLY

FSB Premier Wealth Management's LLY Position: Q2 2026 in Review

FSB Premier Wealth Management increased its Eli Lilly (LLY) stake by 66% in Q2 2026, buying an estimated $221K and bringing the position to 542 shares worth $650K. The position accounts for 0.18% of the portfolio, ranked #127.

FSB Premier Wealth Management first reported a position in LLY in Q4 2021 and has held it in 3 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FSB Premier Wealth Management held 542 shares of Eli Lilly worth $650K as of Q2 2026.
  • FSB Premier Wealth Management bought 216 Eli Lilly shares in Q2 2026, an estimated $221K.
  • Eli Lilly made up 0.18% of FSB Premier Wealth Management's portfolio in Q2 2026, its #127 holding.
  • FSB Premier Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 3 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FSB Premier Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.